This in vitro microperfusion study examined the effects of growth hormone and insulin-like growth factor I (IGF-I) on proximal convoluted tubule (PC1) transport. Tubules were perfused with an ultrafiltrate-like solution and bathed in a serumlike albumin solution. Neither a physiologic (5 X 10-10 M), nor a pharmacologic (5 X 10j-M) dose of growth hormone had an effect on PCT phosphate or bicarbonate transport, or volume absorption. Addition of 5,x 10-9 M and 5 X 108 M IGF
Introduction
There is substantial evidence that growth hormone affects renal function (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Growth hormone excess, whether from endogenous hypersecretion or chronic exogenous administration, has been associated with an increase in renal blood flow, glomerular filtration rate (1) (2) (3) (4) (5) (6) , and increased levels of serum phosphate (7-9, 13-15). Administration ofgrowth hormone to dogs increased glomerular filtration rate, serum phosphate, and the maximal rate of tubular phosphate reabsorption, effects independent of parathyroid hormone (8) . Brush border membrane vesicles prepared from the renal cortex of dogs treated with growth hormone for 3 d had an increase in sodium-dependent phosphate uptake (16) . Likewise, hypophysectomized animals had a reduction in renal blood flow and glomerular filtration rate, effects reversed by growth hormone administration (1, 10, 11) . Selective growth hormone deficiency, induced by administration ofa synthetic peptide antagonist to growth hormone releasing factor, resulted in a reduction in glomerular filtration rate and increased the fractional excretion of phosphate ( 12) .
While chronic growth hormone administration produces renal hemodynamic changes and modulates phosphate transport, acute administration of growth hormone does not produce these changes (5, 6, 17, 18) . Renal blood flow, glomerular filtration rate, and tubular reabsorption ofphosphate remained stable 2 h after growth hormone administration in normal and thyroparathyroidectomized dogs (17) . Similarly, renal blood flow and glomerular filtration rate remained stable for 6 h in man after growth hormone administration (5, 6, 18) . However, on the second and third day after a single injection of growth hormone, there was a rise in renal blood flow and glomerular filtration rate (5, 6) . The increase in these parameters paralleled a rise in serum insulin-like growth factor I (IGF-I)' levels, and occurred at a time when growth hormone levels had returned to normal. In normal human subjects, infusion of IGF-I increased creatinine clearance and decreased plasma creatinine and urea levels (19) . IGF-I increased renal plasma flow and glomerular filtration rate in fasted rats within 40 min of infusion (20) . Thus, these studies suggest that the hemodynamic and tubular effects of growth hormone may be mediated by IGF-I.
The proximal tubule has both growth hormone and IGF-I receptors (21) (22) (23) (24) (25) . It has been demonstrated recently that growth hormone has direct effects on this epithelium in the absence of IGF-I (22) . Growth hormone produced an increase in phospholipase C activity when added to proximal tubular basolateral membranes. Addition ofgrowth hormone to proximal tubule suspensions stimulated gluconeogenesis (26, 27) and ammoniagenesis (27) . Whether growth hormone directly affects proximal tubule transport or acts indirectly via IGF-I is not known. The purpose of this in vitro microperfusion study was to determine if growth hormone and IGF-I can directly modulate transport in the proximal tubule.
Methods
Isolated segments ofproximal convoluted tubules (PCT) were perfused as previously described (28, 29 The transepithelial potential difference (PD, millivolts) was measured by using the perfusion pipette as the bridge into the tubular lumen. The perfusion and bathing solutions were connected to the recordingand reference calomel half-cells usinga bridge containing the perfusate in series with a 3.6 M KC1/0.9 M KNO3 agarose bridge. This arrangement avoided direct contact between the KC1/KNO3 agarose bridge and the solution bathing the tubule. The recording and reference calomel half-cells were connected to the high and low impedance sides, respectively, of an electrometer (model 602; Keithley Instruments, Inc., Cleveland, OH).
To determine if growth hormone (Eli Lilly, Indianapolis, IN) directly affects PCT transport, tubules were perfused with an ultrafiltratelike solution and bathed in a serum-like albumin solution. During the experimental period either 0, 5 X 10'0, or 5 X I0`8 M growth hormone was added to the bath. 5 x 10-8 M growth hormone was added to the luminal perfusate in additional studies to determine ifgrowth hormone had a direct effect on the apical membrane.
To determine if bath IGF-I affects PCT transport, tubules were again perfused with an ultrafiltrate-like solution and bathed in a serumlike albumin solution. During the experimental period either 0, 5 X 10-10, 5 X 10-9, or 5 X I0O-M IGF-I (Amgen Biologicals, Thousand Oaks, CA) was added to the bathing solution. Because IGF-I is known to cause phosphorylation of its own receptor and subsequent phosphorylation of other intracellular proteins, an apparent increase in JF%,.
could be due to an increase in cellular uptake and utilization of phosphate, and not to an increase in the transepithelial transport of phosphate. To examine this possibility, 32P04 accumulation in the bath was Three 1-ml samples of bath from both the control and experimental periods were counted for 32PO4 and then averaged for each experiment.
The lumen to bath flux of phosphate was then calculated from the rate of appearance of 32PO4 in the bath. In the last series of experiments IGF-I was added to the luminal perfusate to determine if IGF-I had an effect on transport via the apical membrane. During the experimental periodeitherO, 5 X 10-12, 5 X 10-11, 5 X 10',or5 X I0-MIGF-Iwas added to the luminal perfusate. There were four to six measurements of PD, volume absorption, bicarbonate transport, and phosphate transport in each period in all tubules. The mean value for individual periods in a given tubule was used to calculate the mean for that period. Data are expressed as mean±SEM. The t test for paired data was used to determine significance at the 0.05 level.
Results
Effect of lumen and bath growth hormone on PCT transport. The first series of experiments examined whether growth hormone has a direct effect on PCT transport. These results are shown in Table I . The mean tubular length for these experiments was 1.5±0.1 mm. Time controls were done to ensure the stability of our preparation. In these experiments vehicle, rather than hormone, was added during the experimental period. There was a small but statistically significant increase in the PD with time, but volume absorption, phosphate and bicarbonate transport remained constant. An increase in PD with time has been found previously in the in vitro PCT (31, 32) . A physiologic concentration of bath growth hormone (5 x 10-10 M) had no effect on volume absorption, bicarbonate or phosphate transport, but caused a small significant increase in PD, comparable to that observed in the time control studies. The concentration ofgrowth hormone used was similar to peak plasma levels in humans during puberty (33) , and to the concentration that caused half-maximal stimulation ofphospholipase C activity in canine proximal tubular basolateral membranes (22) . A pharmacologic concentration of growth hormone (5 X 10-8 M) also had no effect on PCT volume absorption, or bicarbonate or phosphate transport when added to the bath.
Because growth hormone is filtered, the effect of luminal growth hormone was also examined (34, 35) . Addition of 5 X 10-8 M growth hormone to the luminal perfusate had no effect on PCT transport (Table I) IGF-I, but there was no effect on volume absorption at bath IGF-I concentrations of 5 X 10`1 M and 5 X 10-8 M. There was no change in bicarbonate transport at any bath IGF-I concentration. However, 5 X I0-' M and 5 X 1O-8 M IGF-I stimulated phosphate transport by 15% and 12%, respectively. Thus, bath IGF-I causes a significant increase in phosphate transport, but no significant change in bicarbonate absorption.
To determine ifthe increase in phosphate transport was due to an increase in uptake and metabolism of phosphate, or to a true increase in transepithelial transport, the bathing solution was analyzed for 32PO4 in three of the experiments examining the effect of 5 X 1O-8 M bath IGF-I on proximal tubule transport. These results are shown in Table III . The lumen to bath flux of phosphate was calculated from the appearance rate of 32P04 in the bath. These data are in close agreement to the fluxes calculated from the perfused and collected fluid phosphate concentrations, confirming that there was a significant increase in transepithelial phosphate transport in the presence of bath IGF-I.
The last series of experiments examined the effect of luminal IGF-I on PCT transport. During the experimental pe- (21, 22) . Growth hormone has been shown to bind to receptors present in the basolateral membrane vesicles isolated from canine renal cortex and stimulate phospholipase C activity (22) . Half-maximal stimulation ofphospholipase C activity occurred at 5 X 10-10 M growth hormone and was noted within 15 s ofincubation with growth hormone. Growth hormone has been shown to stimulate gluconeogenesis in rat kidney cortical slices (36) , and in suspensions of canine proximal tubules (26, 27) . In these latter studies 10-6 M growth hormone increased glucose production by 55% after 120 min of incubation. The half-maximal response occurred between 10-' M and 1o-8 M growth hormone (26, 27) . Growth hormone also increased ammoniagenesis, where half-maximal stimulation occurred at a concentration between 10-10 M and 10-9 M (27).
The acute effect of growth hormone on tubular phosphate reabsorption has been examined in dogs (17) . Dogs received a growth hormone infusion for 2 h, then inulin and para-aminohippurate clearances and phosphate reabsorption were measured over the subsequent 2 h. There was no significant change in renal blood flow, glomerular filtration rate, or tubular reabsorption of phosphate in these dogs, results which agree with our findings. In this study, the concentrations of growth hormone used are well within the range of those that have been previously reported to stimulate phospholipase C activity, gluconeogenesis, and ammoniagenesis in the proximal tubule (22, 26, 27, 36) . The total time ofincubation with growth hormone during the experimental period was 90-120 min. This is comparable to the time of incubation where growth hormone has been shown to increase ammoniagenesis and gluconeogenesis (26, 27, 36) .
Serum IGF-I levels increase after growth hormone administration and could mediate the effects of growth hormone on phosphate transport. Hypophysectomized rats given IGF-I via osmotic minipump for 6 d had an elevated serum phosphate and an increased maximal rate oftubular reabsorption ofphosphate (37). Brush border membrane vesicles isolated from the renal cortex of these animals had a higher Na-dependent Pi transport, compared to vehicle treated controls. Sodium-dependent glucose and alanine uptake were not affected. The stimulatory effect of IGF-I on maximal rate of tubular reab-sorption of phosphate was also observed in thyroparathyroidectomized animals indicating that IGF-I's action was independent of parathyroid hormone.
Serum 1,25-dihydroxyvitamin D3 levels have correlated well with serum IGF-I levels under a number of experimental conditions (38, 39) . Infusion of IGF-I in hypophysectomized rats increased serum 1,25-dihydroxyvitamin D3 levels (37). Since 1,25-dihydroxyvitamin D3 stimulates phosphate transport (40, 41) , the effect of IGF-I in vivo could have been mediated by 1-25-dihydroxyvitamin D3. Our study, however, demonstrates a stimulation ofphosphate transport by IGF-I in the absence of 1,25-dihydroxyvitamin D3.
The acute effect of IGF-I on phosphate transport has been studied in a cell culture line derived from opossum kidneys (42) . These cells have sodium-dependent phosphate transport that is inhibited by parathyroid hormone (43, 44) . IGF-I stimulated sodium-dependent phosphate uptake within 15 min of incubation (42) . Half-maximal stimulation occurred at a dose of lo-' M IGF-I, and maximal stimulation was found at lo-' M IGF-I. Kinetic analysis demonstrated an increase in V.
with no change in the Km for phosphate transport. It was also noted that the effect was specific for phosphate transport since the transport of alanine was not affected.
These studies examined the effect of IGF-I on proximal tubule transport. In vitro microperfusion of individual PCT demonstrated that bath IGF-I stimulated phosphate transport, but did not change volume absorption or bicarbonate transport. The concentration of bath IGF-I that increased phosphate transport (5 X 10-' M) was similar to that found in the cell culture studies (42) . This concentration of IGF-I was that required for half-maximal binding to IGF-I receptors on basolateral membranes (23) (24) (25) , and the concentration that caused autophosphorylation of the ,8-subunit of the IGF-I receptor (45) .
Receptors for IGF-I are present on both the basolateral and apical membranes of the proximal tubule with the density of receptors greater on the basolateral membrane (24 IGF-I is produced by several organs in the body including the liver, lungs, heart, and kidneys (49) . The tissue concentrations of IGF-I in these organs decreases with hypophysectomy and increases when the animal is treated with growth hormone. Recent evidence has shown that rat collecting ducts produce IGF-I in direct response to growth hormone (50) . The significance of this finding is not clear. The major site of phosphate transport is the proximal tubule. It has been postulated that the IGF-I from the collecting duct cells may traverse the interstitium or travel via the vasa rectae to capillaries surrounding the proximal tubule (21) . In this manner IGF-I synthesized by the distal nephron may influence phosphate transport by the proximal tubule. This in vitro microperfusion study directly addressed the issue of whether growth hormone or IGF-I affects proximal tubular transport. These studies were performed in the rabbit PCT and species differences are possible. However, our study demonstrates that while growth hormone had no effect on PCT transport, IGF-I stimulated directly phosphate transport in the rabbit PCT. This stimulation is specific for phosphate as volume absorption and bicarbonate transport remained unchanged. The stimulation in transport by IGF-I is much greater when presented to the apical membrane and suggests that apical receptors may play an important role in the regulation of phosphate transport in the proximal tubule.
